CN Patent
CN101626756A — 非粘膜粘着性膜剂型
Assigned to APR Applied Pharma Research SA · Expires 2010-01-13 · 16y expired
What this patent protects
本发明提供用于递送活性药剂的口腔崩解膜剂型、配制该剂型以延缓通过口腔粘膜进行吸收的方法以及使用该剂型来治疗多种医疗病症的方法。
USPTO Abstract
本发明提供用于递送活性药剂的口腔崩解膜剂型、配制该剂型以延缓通过口腔粘膜进行吸收的方法以及使用该剂型来治疗多种医疗病症的方法。
Drugs covered by this patent
- Zofran (ondansetron) · GSK (originally Glaxo)
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.